ZLD2218

Overview

Considerable studies confirmed that BRD4 inhibition ameliorated kidney injury and fibrosis ，and ZLD2218 exhibited the most potent inhibitory activity against BRD4, with the IC 50 value of 107 nM

Application

Products | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Others | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-144236
• CAS No.: 2713974-32-2
• Molecular Formula: C22H18N4O
• Molecular Weight: 354.40
• Purity: 99.24%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source